Home › OMEICOS Receives BMBF Research Grant To Advance Its Novel Approach To Treat Atrial Fibrillation
 

Keywords :   


OMEICOS Receives BMBF Research Grant To Advance Its Novel Approach To Treat Atrial Fibrillation

2015-11-03 05:07:41| drugdiscoveryonline News Articles

OMEICOS Therapeutics, a biopharmaceutical company developing first-in-class small molecule therapeutics for the prevention and treatment of cardiovascular diseases including atrial fibrillation, recently announced the approval of an approximately €1.7Mgrant by the German Ministry of Education and Research (BMBF)

Tags: research approach advance grant

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
08.07Tropical Storm Beryl Potential Storm Surge Flooding Map
07.07Tropical Storm Beryl Probabilistic Storm Surge Graphics
07.07Tropical Storm Beryl Graphics
07.07Tropical Storm Beryl Forecast Discussion Number 37
07.07Tropical Storm Beryl Storm Surge Watch/Warning Map
07.07Tropical Storm Beryl Wind Speed Probabilities Number 37
07.07Tropical Storm Beryl Public Advisory Number 37
07.07Summary for Tropical Storm Beryl (AT2/AL022024)
More »